LNTH News and Press, Lantheus Holdings Inc. From 12/17/23

2023-12-17 09:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-11-12 08:36:13 ET Summary Lantheus experienced tremendous growth in the last two years thanks to the approval of a new imaging agent called PYLARIFY. The company now faces several catalysts including the approval of PYLARIFY in Europe and the commercialization of PNT2002 and ...

2023-11-03 06:10:25 ET Lantheus Holdings, Inc. (LNTH) Q3 2023 Earnings Conference Call November 02, 2023, 08:00 AM ET Company Participants Mark Kinarney - Vice President of Investor Relations Mary Anne Heino - Chief Executive Officer Paul Blanchfield - President ...

2023-11-02 07:09:05 ET More on Lantheus Lantheus: Fast-Growing Radiotherapeutics Specialist Can Benefit From Lilly's POINT Biopharma Takeover Lantheus: Growth Well Priced In, Profitability Next Hurdle (Rating Downgrade) Lantheus: Not Quite Ready To Take The Plunge ...

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

Worldwide revenue of $319.9 million for the third quarter 2023, representing an increase of 33.7% from the prior year period GAAP net income of $132.0 million for the third quarter 2023, compared to GAAP net income of $61.2 million in the prior year period GAAP fully diluted net i...

Lantheus Holdings Inc. (LNTH) is expected to report $1.19 for Q3 2023

2023-11-01 13:02:03 ET More on Lantheus Lantheus: Fast-Growing Radiotherapeutics Specialist Can Benefit From Lilly's POINT Biopharma Takeover Lantheus: Growth Well Priced In, Profitability Next Hurdle (Rating Downgrade) Lantheus: Not Quite Ready To Take The Plunge ...

BEDFORD, Mass., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, November 2, 2023, to discuss its financial and operating results for the third qu...

2023-10-12 16:35:30 ET Summary Lantheus Holdings' stock price has increased more than 1000% since its IPO in 2015, with most gains occurring since 2022. The success of its product PYLARIFY, a PSMA-targeted PET imaging agent for prostate cancer, has driven significant revenue growt...